��ɫ��

Resources For

Abstract Details

Title Alemtuzumab Reduces Disease Progression in RRMS: Long-Term Results of the CAMMS223 Trial

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 213

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file